Escolar Documentos
Profissional Documentos
Cultura Documentos
Centre of Health
Professional Education
Evidence
RPA
Guidelines from
ISPAD
ADA
CDA
IDF
etc
Overview
RPA
Evidence
Evidence of implementation
Professional development
RPA
Open mind
Strategies to:
Change things
RPA
RPA
RPA
Evidence Says:
RPA
Eyes,
Kidneys
Feet
etc
RPA
Referring Doctor
Pregnancy
Clinic
High Risk
Foot Clinic
Acute Intervention
Clinic
Complications and
Metabolic Management
(Type 1 & 2)
Follow-Up Clinic
Review Clinic
Complications Assessment
RPA
RPA
Diabetes
Centre
Complications Screening
in 12 months (%)
Eyes review
88
100
86
Lipids Measurement
72
96
92
Microalbuminuria
56
94
72
24
24
27
BP
26
35
28
HbA1c within 1% of
normal range
29
44
41
RPA
applied to practice
RPA
RPA
Research/Practice Gap
findings
RPA
RPA
Abstract
Presentation
Paper
Research In A Multi-disciplinary
Setting: Less Linear Than Thematic
RPA
23
2009 n=562
p<0.0001
25.2
T1D Not on
Metformin, n=67
Mean SD
29.7
T1D on
Metformin,
n=385
WHO 1999 criteria
In prep.
Type 1 Diabetes
N=354
p-value
Duration of
diabetes (yrs)
11.6
[4.5-22.6]
14.0
[7.3-22.2]
0.06
eGFR
98 39.2
93 32
0.3
Retinopathy (%)
37
40
0.5
Albuminuria (%)
47.4
13.1
<0.0001
ACR
2.2
[0.8-12.8]
0.7
[0.4-1.5]
<0.0001
VPT Z score
2.3 1.3
1.8 1.3
<0.0001
Stroke (%)
4.3
0.6
0.002
IHD (%)
12.6
1.6
<0.0001
RPA
Type 1 Diabetes
p-value
49.3
24.8
<0.0001
Systolic BP (mm/Hg)
126 17
122 17
0.02
Diastolic BP
(mm/Hg)
78 10
75 9
<0.0001
38.3
28.8
<0.0003
5.2 1.5
4.9 1.2
0.007
Triglycerides
(mmol/L)
1.9 [1.3-3.0]
1.0 [0.7-1.5]
<0.0001
HDL (mmol/L)
1.2 0.4
1.5 0.4
<0.0001
LDL (mmol/L)
3.0 1.1
2.8 0.9
0.2
41
46
0.2
Antihypertensive
Treatment (%)
Statins (%)
Cholesterol (mmol/L)
RPA
Survival Analysis
educating patients
syndrome
RPA
RPA
RPA
Burnout
Produces helplessness,
hopelessness, and resentfulness
Loss of energy
RPA